Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Dabur sues government...

    Dabur sues government for denied tax sops under GST

    Written by Ruby Khatun Khatun Published On 2018-06-23T23:48:25+05:30  |  Updated On 16 Aug 2021 2:54 PM IST

    MUMBAI: Central and Uttarakhand government have been dragged to court by Dabur for rejecting tax sops for investment in poorer areas promised under the pre-GST tax regime, joining a growing list of firms miffed at the government for denial of such concessions.


    Benefits such as 10-year tax holiday have been availed by Dabura after investing in Uttarakhand's backward areas but the firm has faced problems after the older taxes were subsumed under the GST umbrella after the GST rollout.

    Leading consumer goods companies' suppliers have complained of discrimination and lack of clarity in GST regulations about the tax benefits. While Dabur is one of the first major companies to join the writ petition filed in the Nainital bench of Uttarakhand High Court.


    In certain states, manufacturers investing in backward areas would get indirect tax exemptions from the state governments and sometimes from the central government under the previous tax regime.


    According to a news report in Economic Times, tax experts say that transition of credits on capital investments is allowed under GST but there is no clarity around credit on investments made in industrially marginalized areas. They further added that under the earlier tax regime, there was no tax on the products manufactured or output of manufactures as the inputs—capital expenditure or raw materials—were also tax exempt. In most situations, the taxes on outputs were set off against input tax credits.


    Abhishek A Rastogi, partner, Khaitan & Co told ET, "Since there was a 10-year tax holiday and no taxes on output under the earlier tax regime, there was no question of input credit on capital goods earlier."

    According to the industry trackers, under GST cost of capital expenditure incurred cannot be set off against the GST paid by the companies and this is creating problems for these companies.


    "It is legitimate to expect the proportional credit on capital goods transitioned as the credit was allowed not only in the earlier regime but also in the present regime," added Rastogi who is the arguing for one of the petitioners in the matter.


    Denial of tax sops or tax holidays could mean that many manufacturers may move their facilities to other areas.
    10-year tax holidayAbhishek A RastogiBenefitsDaburdeniedgovernmentGSTindirect tax exemptionssuestax sopsUttarakhandUttarakhand High Court
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok